907 related articles for article (PubMed ID: 17251419)
1. Abeta oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's disease.
Lacor PN; Buniel MC; Furlow PW; Clemente AS; Velasco PT; Wood M; Viola KL; Klein WL
J Neurosci; 2007 Jan; 27(4):796-807. PubMed ID: 17251419
[TBL] [Abstract][Full Text] [Related]
2. Why Alzheimer's is a disease of memory: the attack on synapses by A beta oligomers (ADDLs).
Viola KL; Velasco PT; Klein WL
J Nutr Health Aging; 2008 Jan; 12(1):51S-7S. PubMed ID: 18165846
[TBL] [Abstract][Full Text] [Related]
3. Drebrin in Alzheimer's Disease.
Ishizuka Y; Hanamura K
Adv Exp Med Biol; 2017; 1006():203-223. PubMed ID: 28865022
[TBL] [Abstract][Full Text] [Related]
4. Blocking the Interaction between EphB2 and ADDLs by a Small Peptide Rescues Impaired Synaptic Plasticity and Memory Deficits in a Mouse Model of Alzheimer's Disease.
Shi XD; Sun K; Hu R; Liu XY; Hu QM; Sun XY; Yao B; Sun N; Hao JR; Wei P; Han Y; Gao C
J Neurosci; 2016 Nov; 36(47):11959-11973. PubMed ID: 27881781
[TBL] [Abstract][Full Text] [Related]
5. Protection of synapses against Alzheimer's-linked toxins: insulin signaling prevents the pathogenic binding of Abeta oligomers.
De Felice FG; Vieira MN; Bomfim TR; Decker H; Velasco PT; Lambert MP; Viola KL; Zhao WQ; Ferreira ST; Klein WL
Proc Natl Acad Sci U S A; 2009 Feb; 106(6):1971-6. PubMed ID: 19188609
[TBL] [Abstract][Full Text] [Related]
6. Amyloid beta oligomers induce impairment of neuronal insulin receptors.
Zhao WQ; De Felice FG; Fernandez S; Chen H; Lambert MP; Quon MJ; Krafft GA; Klein WL
FASEB J; 2008 Jan; 22(1):246-60. PubMed ID: 17720802
[TBL] [Abstract][Full Text] [Related]
7. Rosiglitazone prevents amyloid-β oligomer-induced impairment of synapse formation and plasticity via increasing dendrite and spine mitochondrial number.
Xu S; Liu G; Bao X; Wu J; Li S; Zheng B; Anwyl R; Wang Q
J Alzheimers Dis; 2014; 39(2):239-51. PubMed ID: 24150104
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's-associated Abeta oligomers show altered structure, immunoreactivity and synaptotoxicity with low doses of oleocanthal.
Pitt J; Roth W; Lacor P; Smith AB; Blankenship M; Velasco P; De Felice F; Breslin P; Klein WL
Toxicol Appl Pharmacol; 2009 Oct; 240(2):189-97. PubMed ID: 19631677
[TBL] [Abstract][Full Text] [Related]
9. Natural oligomers of the Alzheimer amyloid-beta protein induce reversible synapse loss by modulating an NMDA-type glutamate receptor-dependent signaling pathway.
Shankar GM; Bloodgood BL; Townsend M; Walsh DM; Selkoe DJ; Sabatini BL
J Neurosci; 2007 Mar; 27(11):2866-75. PubMed ID: 17360908
[TBL] [Abstract][Full Text] [Related]
10. Synaptic targeting by Alzheimer's-related amyloid beta oligomers.
Lacor PN; Buniel MC; Chang L; Fernandez SJ; Gong Y; Viola KL; Lambert MP; Velasco PT; Bigio EH; Finch CE; Krafft GA; Klein WL
J Neurosci; 2004 Nov; 24(45):10191-200. PubMed ID: 15537891
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of calcineurin-mediated endocytosis and alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) receptors prevents amyloid beta oligomer-induced synaptic disruption.
Zhao WQ; Santini F; Breese R; Ross D; Zhang XD; Stone DJ; Ferrer M; Townsend M; Wolfe AL; Seager MA; Kinney GG; Shughrue PJ; Ray WJ
J Biol Chem; 2010 Mar; 285(10):7619-32. PubMed ID: 20032460
[TBL] [Abstract][Full Text] [Related]
12. Kalirin-7 prevents dendritic spine dysgenesis induced by amyloid beta-derived oligomers.
Xie Z; Shapiro LP; Cahill ME; Russell TA; Lacor PN; Klein WL; Penzes P
Eur J Neurosci; 2019 May; 49(9):1091-1101. PubMed ID: 30565792
[TBL] [Abstract][Full Text] [Related]
13. Altered synaptic structure in the hippocampus in a mouse model of Alzheimer's disease with soluble amyloid-β oligomers and no plaque pathology.
Price KA; Varghese M; Sowa A; Yuk F; Brautigam H; Ehrlich ME; Dickstein DL
Mol Neurodegener; 2014 Oct; 9():41. PubMed ID: 25312309
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of EphB2 in hippocampus rescues impaired NMDA receptors trafficking and cognitive dysfunction in Alzheimer model.
Hu R; Wei P; Jin L; Zheng T; Chen WY; Liu XY; Shi XD; Hao JR; Sun N; Gao C
Cell Death Dis; 2017 Mar; 8(3):e2717. PubMed ID: 28358367
[TBL] [Abstract][Full Text] [Related]
15. N-methyl-D-aspartate receptors are required for synaptic targeting of Alzheimer's toxic amyloid-β peptide oligomers.
Decker H; Jürgensen S; Adrover MF; Brito-Moreira J; Bomfim TR; Klein WL; Epstein AL; De Felice FG; Jerusalinsky D; Ferreira ST
J Neurochem; 2010 Dec; 115(6):1520-9. PubMed ID: 20950339
[TBL] [Abstract][Full Text] [Related]
16. Histone deacetylase mediates the decrease in drebrin cluster density induced by amyloid beta oligomers.
Ishizuka Y; Shimizu H; Takagi E; Kato M; Yamagata H; Mikuni M; Shirao T
Neurochem Int; 2014 Oct; 76():114-21. PubMed ID: 25058791
[TBL] [Abstract][Full Text] [Related]
17. EphA4 loss improves social memory performance and alters dendritic spine morphology without changes in amyloid pathology in a mouse model of Alzheimer's disease.
Poppe L; Rué L; Timmers M; Lenaerts A; Storm A; Callaerts-Vegh Z; Courtand G; de Boer A; Smolders S; Van Damme P; Van Den Bosch L; D'Hooge R; De Strooper B; Robberecht W; Lemmens R
Alzheimers Res Ther; 2019 Dec; 11(1):102. PubMed ID: 31831046
[TBL] [Abstract][Full Text] [Related]
18. A critical role for the PAR-1/MARK-tau axis in mediating the toxic effects of Aβ on synapses and dendritic spines.
Yu W; Polepalli J; Wagh D; Rajadas J; Malenka R; Lu B
Hum Mol Genet; 2012 Mar; 21(6):1384-90. PubMed ID: 22156579
[TBL] [Abstract][Full Text] [Related]
19. Alzheimer's disease-related amyloid-β induces synaptotoxicity in human iPS cell-derived neurons.
Nieweg K; Andreyeva A; van Stegen B; Tanriöver G; Gottmann K
Cell Death Dis; 2015 Apr; 6(4):e1709. PubMed ID: 25837485
[TBL] [Abstract][Full Text] [Related]
20. NMDA receptors mediate synaptic depression, but not spine loss in the dentate gyrus of adult amyloid Beta (Aβ) overexpressing mice.
Müller MK; Jacobi E; Sakimura K; Malinow R; von Engelhardt J
Acta Neuropathol Commun; 2018 Oct; 6(1):110. PubMed ID: 30352630
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
